Keith Black

Black Light Surgical, Inc. has developed breakthrough technology to revolutionize medical imaging, based on years of research at Cedars-Sinai Medical Center. The company is based in Sunny Isles Beach, FL. The technology incorporates principles of auto-fluorescence lifetime and time-resolved auto-fluorescence spectroscopy, which can be used intra-operatively and is highly accurate in characterizing tissue without the need for dyes or drugs. The company's initial focus is on addressing the long-standing problem of breast cancer, where one-third of patients require a second or third procedure following breast conserving surgery (BCS) to fully remove the cancer.

Black Light Surgical, Inc. has developed breakthrough technology to revolutionize medical imaging, based on years of research at Cedars-Sinai Medical Center. The company is based in Sunny Isles Beach, FL. The technology incorporates principles of auto-fluorescence lifetime and time-resolved auto-fluorescence spectroscopy, which can be used intra-operatively and is highly accurate in characterizing tissue without the need for dyes or drugs. The company's initial focus is on addressing the long-standing problem of breast cancer, where one-third of patients require a second or third procedure following breast conserving surgery (BCS) to fully remove the cancer.

Black Light Surgical, Inc. has developed breakthrough technology to revolutionize medical imaging, based on years of research at Cedars-Sinai Medical Center. The company is based in Sunny Isles Beach, FL. The technology incorporates principles of auto-fluorescence lifetime and time-resolved auto-fluorescence spectroscopy, which can be used intra-operatively and is highly accurate in characterizing tissue without the need for dyes or drugs. The company's initial focus is on addressing the long-standing problem of breast cancer, where one-third of patients require a second or third procedure following breast conserving surgery (BCS) to fully remove the cancer.